Taiwan Bio Therapeutics Inc

NEW
ROCO:6892 (Taiwan)  
NT$ 24.4 -0.10 (-0.41%) Aug 7
At Loss
P/B:
2.83
Market Cap:
NT$ 2.29B ($ 71.13M)
Enterprise V:
NT$ 2.32B ($ 72.01M)
Volume:
40.76K
Avg Vol (2M):
155.95K
Trade In:
Volume:
40.76K
At Loss
Avg Vol (2M):
155.95K

Taiwan Bio Therapeutics Inc (ROCO:6892) Dividend

Taiwan Bio Therapeutics Inc (ROCO:6892) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:6892 Dividend

Does Taiwan Bio Therapeutics Inc (ROCO:6892) pay a dividend?

Taiwan Bio Therapeutics Inc (ROCO:6892) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Taiwan Bio Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Taiwan Bio Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -16.3% over the past 3 years.

What are dividend-paying alternatives to Taiwan Bio Therapeutics Inc?

For dividend-paying alternatives in Taiwan Bio Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.